Although QRS voltages for left ventricular hypertrophy (LVH) are widely recognized as an independent factor for coronary artery disease (CAD), little information is available on reversion of ST-T alterations in hypertensive subjects with electrocardiographic (ECG) criteria for LVH.
Critical Value of the Electrocardiogram in LVH: From Predictive Index to Therapeutic Reassessment
Letter to the Editor: Although QRS voltages for left ventricular hypertrophy (LVH) are widely recognized as an independent factor for coronary artery disease (CAD), little information is available on reversion of ST-T alterations in hypertensive subjects with electrocardiographic (ECG) criteria for LVH.
Two recent articles in Hypertension by Fagard et al 1 and Schneider et al 2 presented the regression of QRS voltages in treated hypertensive subjects without evidence of improvement on ventricular repolarization abnormalities. The first study, the Systolic Hypertension in Europe (Syst-Eur) Trial based on nitrendipine therapy to which enalalpril or thyzide could be added, showed that serial 1 mV increase in QRS voltage predicts cardiovascular morbidity and mortality, whereas a Ϫ1mV regression was associated with lower cardiovascular events, without mention of the ST-T alterations. In the second study, the Cardiovascular Irbesartan Project, the reduction of QRS voltage at 6-and 18-month periods was more significant with irbesartan as compared with atenolol, but no precise information was given on the ST-T changes (see Tables 2 and 4 in the article). It is, therefore, uncertain whether all of these therapeutic measures failed to improve the ventricular repolarization abnormalities or if the investigators failed to report them. This is a critical point because QRS voltage may decrease with the lowering of blood pressure irrespective of derangement of coronary blood supply relative to LV mass. In fact, ST-T changes may precede, occur simultaneously with, or appear after the increase in QRS voltages, 3 whereas the T wave inversion may carry an elevated risk for ischemic heart disease, whether in conjunction with ST depression or increased QRS voltages. 4 Such "minor" alterations, often discarded as clinically meaningless and receiving little attention, provide some explanation for the increasing number of CAD reported in hypertensive subjects despite improved BP control. 5 In this context, we have recently documented how these ST-T alterations in hypertensive subjects with LVH or CAD can be improved or reversed in a significant number of subjects within the first 6 months of treatment, when closer attention is given to each ECG abnormality. 6 In general, these uncompleted reports on ST-T changes in hypertensive subjects with ECG-LVH 1,2 probably result from the use of single QRS voltages criteria, as in the Syst-Eur trial or by the misconception that only "classical" LV strain pattern in V5, V6 is important. It should be remembered that the earliest ECG criteria by Sokolow-Lyon (1949) 7 or DW Romhilt and EH Estes Jr (1968) 8 included both QRS voltage with any ST segment shifts opposite to mean QRS and diphasic or inverted T wave, and that the classical LV strain pattern was included as ECG score for patients on digitalis. It is thus surprising that after several reports from the Framingham Heart Study 9 -11 on the predictive value of ECG-LVH (QRS voltage, ST segment shift, flat or inverted T waves), the prognostic significance of ECG-LVH is universally related to the increased QRS voltages. Other reports, such as LIFE study patients, 12 included typical LV strain but on ECG recorded at a 1-year interval. In this context, a policy of obtaining ECG recordings on a more regular basis (ie, yearly in the absence of ST-T changes, but every 3 months if ST-T minor changes appear) can certainly contribute to an improved ECG diagnosis of subclinical heart disease in hypertensive patients and, more importantly, to a critical reassessment of the therapeutic measures in these patients with LVH.
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